LINC01561: A Protein as A Drug Target for Multiple Diseases (G404216)

Target Name: LINC01561

NCBI ID: G404216

LINC01561

Other Name(s): MGC131689 | long intergenic non-protein coding RNA 1561 | FLJ37402 | Long intergenic non-protein coding RNA 1561 | C10orf85

LINC01561: A Protein as A Drug Target for Multiple Diseases

LINC01561 (MGC131689) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the LINC (long non-coding RNA) family, which are known for their ability to regulate gene expression and play important roles in various cellular processes.

Recent studies have identified LINC01561 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function in these diseases is still being explored, but its potential as a drug target is significant.

One of the reasons for the potential of LINC01561 as a drug target is its expression in a variety of tissues, which makes it a potential target for drugs that can affect multiple organ systems. For example, LINC01561 has been shown to be expressed in the brain, heart, and liver, which are all critical for maintaining human health. This makes it a potential target for drugs that can affect these organs and potentially have a beneficial effect on overall health.

Another reason for the potential of LINC01561 as a drug target is its role in several disease processes. For example, LINC01561 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, LINC01561 has been shown to be involved in the regulation of immune responses, which could make it a potential target for drugs that are used to treat autoimmune disorders.

In addition to its potential as a drug target, LINC01561 has also been shown to have several potential therapeutic applications. For example, LINC01561 has been shown to be involved in the regulation of stem cell proliferation, which could make it a potential target for drugs that are used to stimulate stem cell therapy for a variety of diseases. Additionally, LINC01561 has been shown to play a role in the regulation of cell death, which could make it a potential target for drugs that are used to treat diseases that are characterized by cell death.

Overall, LINC01561 is a protein that is being studied for its potential as a drug target for a variety of diseases. Its expression in multiple tissues and its involvement in several disease processes make it a promising target for drugs that can have a beneficial effect on overall health. Further research is needed to fully understand the function of LINC01561 as a drug target and to determine its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1561

The "LINC01561 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01561 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets